Viewing data from:

AUROVELA 24 FE

ANDA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | A207504 | AUROBINDO PHARMA LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Aurovela 24 Fe (2023)

Total Spending

$4K

Total Claims

Beneficiaries

Avg Cost/Unit

$0.77

Spending Trend

$1K(2019)→$23K(2020)→$80K(2021)→$27K(2022)→$4K(2023)

YoY Change:-28.3%

5yr CAGR:-3.5%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.02MG;1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 15, 2017

No patent or exclusivity listings for this strength.